APIs
patients with locally advanced
metastatic breast cancer after failure o
English name： Docetaxel Anhydrous
Synonyms：N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol; Taxotere
Formula： C43H53NO14
CAS NO. ：114977-28-5
Molecular Weight ：807.88
Specifications:99.5%; 99.0%
Package：500g/tin, also can be packed according to the requirements of customer
Indication：For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer.